Xanthan gum is an anionic extracellular heteropolysaccharide secreted by Xanthomonas campestris under aerobic submerged fermentation, most commonly on glucose or sucrose-based media with controlled nitrogen supplementation. Its primary structure is a linear β-(1→4)-D-glucan backbone with a charged trisaccharide side chain attached at every other glucose unit through α-(1→3) linkages; the side chain consists of β-D-mannose-(1→4)-β-D-glucuronic acid-(1→2)-α-D-mannose, with variable acetyl groups on the internal mannose and pyruvate ketal substitution on the terminal mannose. Commercial lots carry CAS registry 11138-66-2 and EINECS 234-394-2. The weight-average molecular weight is generally reported in the range of 2 × 10⁶–20 × 10⁶ Da, depending on fermentation conditions, downstream recovery, and the analytical method used. Regulatory recognition for food use includes FDA 21 CFR 172.695 as a stabilizer and thickener at good manufacturing practice levels and the designation E415 under EC 1333/2008, while JECFA has assigned an ADI of “not specified.” The powder is normally produced by pasteurization of the fermentation broth, precipitation with ethanol or isopropanol, dewatering, drying, and milling to controlled particle-size ranges. Food and pharmaceutical grades are clarified to reduce cell debris and lower insoluble matter; industrial and oilfield grades may retain measurable cell fragments, protein residues, and fermentation metabolites. Hydration occurs in cold or hot water but not in organic solvents such as ethanol or acetone. Direct addition of dry powder to water without adequate dispersion produces partially hydrated gel lumps because the external powder layer swells and restricts water penetration; on production lines this is managed by premixing with non-solvent humectants, dry sugars, oil, or other powdered ingredients before the aqueous phase is introduced under high-shear mixing. The polysaccharide is resistant to many cellulolytic enzymes because of the side-chain steric shielding, but oxidative depolymerization can occur in the presence of strong oxidizers such as hypochlorite, persulfate, ozone, or hydrogen peroxide in acidic conditions. The native double-helical conformation dissociates upon heating and order–disorder transitions influence solution viscosity; formulations relying on yield stress should be processed below the transition temperature or rapidly cooled after heat treatment to restore the ordered network. Industrial handling requires dust control, because the fine powder forms a slippery hydrated film when spilled and wet surfaces become hazardous during clean-up.In rheological terms, xanthan gum is strongly pseudoplastic in aqueous solution, with low-shear viscosity several orders of magnitude above high-shear viscosity. Viscosity is commonly measured by rotational viscometry under ASTM D2196 or DIN 53019-1; for a 1 wt% solution in 1% KCl at 25 °C, representative food-grade medium-viscosity powders report apparent viscosities of 1,200–1,600 mPa·s at 60 rpm with a Brookfield LV spindle, although low-viscosity grades may fall below 600 mPa·s and clarified high-pyruvate grades can exceed 1,800 mPa·s under identical conditions. The flow-curve power-law index typically lies between 0.2 and 0.4 for concentrations of 0.1–1.0 wt% in low-to-moderate salt backgrounds. At rest, xanthan solutions behave as yield-stress fluids because intermolecular associations and the high molecular weight create a weak gel network that suspends solid particles. This is exploited in particulate suspension where the fluid must exhibit a yield stress greater than the gravitational stress of the dispersed phase. Ionic strength has a complex effect: low levels of monovalent salts such as sodium chloride or potassium chloride lower electrostatic repulsion along side chains and can slightly increase low-shear viscosity, whereas high levels above approximately 2–4% NaCl or saturated KCl reduce hydration rate and may require prehydration in fresh water before brine addition. Divalent cations such as calcium and magnesium are generally tolerated under neutral to acidic conditions, but at alkaline pH above 9.0 they can produce syneresis or localized gelation when the polymer is exposed to concentrated brines. The polymer is stable over the pH range of approximately 4.5–8.5 for long-term use; below pH 3.5 acid hydrolysis of glycosidic linkages accelerates at elevated temperature, and above pH 10 alkaline peeling reactions and deacetylation may reduce viscosity. Xanthan is also compatible with many water-miscible solvents at low concentration, but hydration is prevented above approximately 30–40% ethanol or glycerol depending on grade, so stock solutions are normally prepared in water and then diluted into the final solvent system.Thermal stability in oilfield and industrial brines is controlled by oxygen content, dissolved metal ions, pH, and the degree of pyruvate substitution rather than by a single degradation temperature. In deoxygenated neutral monovalent brines, xanthan can retain useful viscosity for extended periods at 60–70 °C; above 80 °C, depolymerization proceeds through hydrolytic chain scission and oxidative radical mechanisms unless oxygen scavengers and sacrificial antioxidants are present. In sodium chloride or potassium chloride brines typical of drilling and completion operations, low-shear viscosity can decline by 20–40% within days when air is not excluded, whereas vacuum deaeration and treatment with sulfite, erythorbate, or proprietary oxygen scavengers reduce the degradation rate. Under high-temperature reservoir conditions above 90 °C, the ordered helical conformation unfolds and the polymer becomes more susceptible to cleavage at glycosidic linkages. At 120 °C and above, published data for this specific configuration is limited, but short-term exposure generally produces irreversible viscosity loss and the polymer is no longer considered a reliable mobility-control agent. Divalent cations in the brine are particularly problematic at elevated temperature: calcium chloride concentrations above 2–5 wt% at 70–80 °C can induce precipitation or phase separation if the polymer concentration exceeds 1,500 ppm. Buffering the system with sodium bicarbonate or organic acids to maintain pH between 5.5 and 7.5 reduces thermal hydrolysis. Biocide selection also affects thermal stability; glutaraldehyde and tetrakis(hydroxymethyl)phosphonium sulfate are commonly used with xanthan, but strong oxidizer-based biocides such as hypochlorite or peracetic acid cause immediate viscosity loss. In production-scale polymer flooding equipment, oxygen ingress occurs through low-pressure suction lines, unblanketed storage tanks, and makeup water; successful preservation therefore requires not only chemical treatment but also closed-system design and nitrogen blanketing on the feed tanks. Thermal degradation is monitored by filter ratio testing, viscosity retention curves, and gel-permeation chromatography; offline viscosity measurement alone can mask molecular weight loss because low-shear viscosity may remain temporarily elevated through aggregation of partially degraded chains.In cold water drilling fluid preparation, the rate-limiting step is usually hydration rather than ultimate rheology. Xanthan gum powders with coarse particle sizes and hydrophobic surface treatments disperse when added to seawater at 4–10 °C, but the polymer may require 30–60 minutes of recirculation through high-shear mud hoppers or centrifugal pumps to reach full viscosity. The addition sequence is critical in high-salt systems: polymer added directly to saturated NaCl or seawater hydrates more slowly than polymer prehydrated in low-salinity water, and viscosity development can lag by 30–50% at equal solids loading. In drilling fluids, typical xanthan concentrations for viscosification range from 0.25 to 1.0 lb/bbl, equivalent to approximately 0.07–0.3 wt%, depending on mud weight and hole cleaning requirements. At these levels the polymer provides cuttings suspension at low annular velocities and shear-thins through the bit nozzles, where the shear rates exceed 10,000 s⁻¹. Field-grade products are dry-blended with starch, polyanionic cellulose, or partially hydrolyzed polyacrylamide to tailor the rheological profile. The API filtration test uses a API 200 screen and standard filter press, but polymer-specific filter ratio measurements under API RP 63 are more informative for reservoir drill-in fluids because xanthan can blind low-permeability formations if residual cell debris or aggregated microgels are not removed. For reservoir applications, clarified grades with low insoluble residue are specified; injection through cartridge filters of 1.2 µm absolute rating may be required for completion brines. A recurring production bottleneck is that high-shear mixing at the surface can mechanically degrade the polymer before it reaches the bit; repeated passes through centrifugal pumps and narrow-gap valves reduce molecular weight and lower low-shear viscosity. To limit this, progressive cavity pumps and low-shear addition hoppers are used rather than high-speed centrifugal recirculation when the fluid has reached target viscosity. Cold conditions also slow initial hydration, so operators may prehydrate xanthan in freshwater tanks for 15–30 minutes before adding salt and weighting agents such as barite or calcium carbonate. If the fluid requires a pH above 9.5, borate or caustic additions can crosslink the polymer and produce an unworkable gel, especially in the presence of divalent ions.Polymer flooding for enhanced oil recovery uses xanthan gum at lower concentrations, often 300–1,500 ppm, to increase the water-phase viscosity and improve the mobility ratio. In this role the polymer must pass through porous media without significant mechanical shearing, so filtration ratio and screen factor tests are applied to predict injectivity. Brine salinity and hardness influence the conformation of the polymer in solution; in high-salinity waters the coil contracts and the intrinsic viscosity is lower than in freshwater, requiring upward adjustment of polymer concentration. Xanthan is generally less shear-stable than high-molecular-weight synthetic polyacrylamides under high-velocity flow through chokes and perforations, but it is more tolerant of monovalent and divalent salts and can be used where the produced water is highly saline. Biodegradation is controlled by maintaining a residual biocide concentration in the make-up water and by limiting residence time in surface tanks under aerobic conditions. In some field configurations, polymer injection lines are designed for laminar flow; excess pressure drop occurs if the polymer is overconcentrated or incompletely hydrated, and remediation requires dilution, heating, or additional shear mixing. Published data for specific reservoir mineralogy and crude oil composition is limited, so coreflood testing is generally required before field-scale implementation.The distinction between xanthan gum grades is not defined by a single chemical reaction but by differences in biomass removal, alcohol precipitation, drying conditions, particle-size reduction, and analytical release limits. Food-grade xanthan gum is a clarified product with low microbial plate counts and pyruvic acid content not less than 1.5% on the dried basis, as required by the FCC monograph and reflected in the USP-NF specification. The pH of a 1% aqueous dispersion is typically controlled to 5.0–8.0, loss on drying is specified at not more than 15%, and total ash is generally constrained in the range of 6.5–16% depending on salt form. Pharmaceutical-grade material is manufactured under higher microbial control with lower endotoxin recovery when used in oral or mucosal products, but powdery xanthan is not typically used as a parenteral excipient because the high molecular weight and particulate microgel character raise concerns for intravenous administration. Industrial and oilfield grades may have lower pyruvate content, higher cell debris, and coarser particle distribution to reduce cost and improve open-plant handling; these grades are not suitable for food or pharmaceutical use because they do not meet the microbial and heavy metal requirements of food chemical monographs. Cosmetic grades are typically clarified and preserved or supplied as dry powders that meet microbial limits for skin application under EC 1223/2009.Grade classManufacturing route and purityRelevant standard or monographCritical processing boundaryFood gradeClarified broth, ethanol or isopropanol precipitation, drum drying, milling to controlled sieve size; low insoluble matterEC 1333/2008; FDA 21 CFR 172.695; FCC; USP-NFHydration pH 4.5–8.5; preservative required in high-water formulationsPharmaceutical gradeClarified, filtered, low endotoxin and low microbial release; particle size controlled for reproducible dispersionUSP-NF Xanthan Gum; Ph. Eur. monographElectrolyte compatibility; viscosity stability in buffer systemsIndustrial or oilfield gradeCrude broth with retained cell debris, coarser milling, lower pyruvate; may contain process saltsISO 13500:2008 for drilling fluid materials; API RP 63 for filtrationPrehydration before brine addition; avoid strong oxidizer biocidesCosmetic gradeClarified, low ash, controlled microbial quality; fine powder for cold processingEC 1223/2009; INCI Xanthan GumUse with preservatives in hydrous emulsions and gelsVariation in pyruvate substitution and acetate content influences both viscosity yield and thermal stability. Pyruvic acid content in commercial food-grade lots commonly ranges from 1.5% to 4.0%; higher pyruvate substitution generally correlates with higher low-shear viscosity and greater salt tolerance, but the correlation is not linear because molecular weight distribution and residual biomass also contribute. Acetate content affects the order–disorder transition temperature; deacetylated xanthan has been reported to show altered gelation behavior with galactomannans and borate complexes. In blend development, xanthan is synergistic with locust bean gum and guar gum: mixtures at ratios between 1:1 and 1:4 can produce gel strengths higher than either gum alone because the unsubstituted mannan regions interact with the xanthan helix. Konjac glucomannan and xanthan form thermoreversible gels at total gum concentrations below 1 wt%, a property used in heat-stable gelled desserts and restructured foods. These synergistic systems depend on mannan purity, molecular weight, and the degree of galactose substitution, so batch-to-batch viscosity differences of 10–15% may occur when crude industrial xanthan is substituted for clarified food-grade material in the same formulation.Beverage processing lines introduce xanthan gum after dry blending with sugar or other soluble powders to prevent lumping, and the slurry is then passed through a high-shear mixer or tri-blender before the acid source is added. In cold-filled acidified beverages at pH between 3.0 and 3.8, xanthan is used at 0.02–0.1 wt% to suspend fruit pulp, insoluble calcium salts, or flavor emulsions without significantly increasing perceived mouthfeel viscosity. The low concentration is effective because of the yield stress generated by the polymer network, not because of high apparent viscosity at swallowing shear rates. Beverage stability is evaluated by accelerated settling tests at 40 °C for 4–12 weeks, with particle suspension verified by measuring sediment height or turbidity in the upper phase; rotational viscometry under ASTM D2196 alone is insufficient to predict shelf stability. Xanthan gum is compatible with citric, malic, and phosphoric acid in typical beverage concentrations, but prolonged storage at temperatures above 35 °C can reduce molecular weight, particularly when ascorbic acid and oxygen are present. In pasteurized beverages, the polymer is added before thermal treatment; the viscosity drops during the heating step and recovers substantially on cooling if the holding time and temperature do not exceed the degradation threshold. Direct steam injection heating exposes the solution to high-temperature short-time shear, which can be more damaging than plate heat exchanger processing because of localized turbulence and air entrainment. For beverages containing dairy proteins, xanthan can form translucent coacervates or lose suspension capacity at pH near the protein isoelectric point, so the sequence of protein stabilizer, xanthan, and acid addition must be controlled. In plant-based beverages, the polymer is used with gellan gum, pectin, or carboxymethylcellulose to prevent particle separation and chalkiness; concentrations above 0.15 wt% may produce a weak gel that interferes with bottle filling and cleaning-in-place operations.Food applications outside beverages rely on the same yield stress, freeze–thaw stability, and acid tolerance, but the processing constraints differ. In spoonable salad dressings, xanthan at 0.1–0.3 wt% stabilizes oil-in-water emulsions and clings to lettuce surfaces; shear during cooling and pumping is lower than in beverage processing, so batch viscosity is maintained. The gum is typically dispersed in the oil phase or dry-blended with spices and sugar before vinegar and water are added under agitation. In frozen dairy and non-dairy desserts, xanthan at 0.05–0.2 wt% retards ice crystal growth through ice-structuring and matrix viscosity, but over-stabilization leads to a chewy texture and poor meltdown behavior. In gluten-free bakery systems, xanthan is added at 0.1–0.5 wt% of total formulation weight to provide dough extensibility, gas retention, and crumb structure; the powder is preblended with starch or non-fat dry milk and hydrated during mixing. Fermentation tolerance is limited because xanthan is not a fermentable substrate for baker’s yeast and residual ionic strength from salt can affect dough rheology. In meat and poultry injection brines, xanthan is sometimes used at 0.05–0.1 wt% to reduce syneresis and improve water holding, but filtration or needle clogging can occur if the gum is not fully dispersed. In reduced-fat spreads and dairy analogues, xanthan is co-processed with starch, milk protein, or gelatin to simulate the melt and mouthfeel of fat; published data for specific commercial products is limited, but the general performance window has been described in food ingredient technical bulletins.In ceramic slip and glaze formulations, xanthan gum is added at 0.1–0.5 wt% on dry solids to prevent settling of feldspar, clay, and quartz particles during storage and spray-drying. The polymer must be dispersed before the clay fraction swells; in production mills, it is added as a dry blend with bentonite, soda ash, or sodium silicate through a vibrating hopper into a recirculating mixing tank. The resulting slip exhibits a low plastic viscosity at high shear in the mill and a high low-shear viscosity at rest, which reduces sediment on tank bottoms and transfer lines. The stability is affected by soluble calcium from hard water and ceramic raw materials; if calcium ion activity is high, the polymer may require sequestration with sodium tripolyphosphate or polyacrylate dispersants. In latex paint, xanthan is used at 0.05–0.3 wt% of formula weight to provide sag resistance, roller spatter reduction, and pigment settling control at pH 8.0–9.0. The polymer forms a shear-thinning network that complements associative thickeners and cellulosic ethers; overdosage creates excessive low-shear viscosity, poor leveling, and brush drag. Biocide protection is mandatory in waterborne paints because bacterial growth fed by residual fermentation nutrients can degrade the gum and produce odors. In mineral processing, xanthan is used as a slurry stabilizer and viscosity modifier in grinding circuits, but published data for specific configurations is limited. The polymer is also applied in textile pigment printing pastes at 0.5–1.5 wt% to produce crisp print edges and low screen clogging; after printing, the paste is washed off, so crosslinking and water resistance are not generally required. In agrochemical spray formulations, xanthan at 0.01–0.1 wt% reduces driftable fines and suspends insoluble active ingredients; however, high tank-mix salinity or pH outside 5.0–8.0 can reduce hydration and lead to nozzle clogging.In pharmaceutical and cosmetic suspensions, xanthan gum provides yield stress for insoluble actives such as barium sulfate, zinc oxide, or insoluble drug particles. Typical concentrations in oral suspensions are 0.1–0.5 wt%, often in combination with microcrystalline cellulose, carmellose sodium, or bentonite to adjust pourability and sedimentation volume. The polymer hydrates in the aqueous phase before the active is dispersed, and the final viscosity is checked under USP or equivalent rotational viscometry. At low pH, the gum can be combined with antacids and salts but may show slight viscosity reduction due to reduced electrostatic repulsion. In topical gels and lotions, xanthan is used at 0.05–0.3 wt% and is often blended with glycerin or propylene glycol before water addition to avoid lumping. The polymer is compatible with nonionic emulsifiers and many anionic surfactants, but incompatible with high concentrations of cationic surfactants because electrostatic complexation can precipitate the polymer. For mucosal and ophthalmic products, osmolarity adjustment and preservative compatibility must be evaluated; benzalkonium chloride can form complexes with the anionic polymer and reduce antimicrobial efficacy, so alternative preservatives or reduced concentrations are used. In controlled-release matrix tablets, xanthan gum hydrates to form a gel layer that retards drug diffusion; the release rate depends on tablet compression force, polymer concentration, and the ionic strength of the dissolution medium. Dissolution testing under USP with pH change from 0.1 N HCl to phosphate buffer shows that the polymer is less effective at low pH than at neutral pH because hydration and gel-layer formation are faster at higher pH. Batch-to-batch release profiles can shift when tablet hardness or particle size of the gum is not controlled, since coarse particles hydrate slowly and alter the initial gel layer. The dry powder should be stored below 25 °C and protected from humidity above 60% RH to prevent caking and microbial proliferation in non-sterile excipient stores.

Commercial feed-grade lysine is represented by three principal trade forms: crystalline L-lysine monohydrochloride, lysine-rich fermentation biomass sold as L-lysine sulfate, and concentrated liquid L-lysine base. The hydrochloride salt has the empirical formula C6H14N2O2·HCl and a molar mass of 182.65 g/mol; the L-lysine base fraction is 80.03%, so a product meeting 98.5% salt purity contains not less than 78.8% L-lysine base. The sulfate form is a granulated fermentation product that retains dried Corynebacterium glutamicum biomass, residual peptides, sulfate, and soluble carbohydrates; the declared lysine base content is not less than 55%, and the product therefore also contributes crude protein, minerals, and fermentable carbohydrates to the diet. Liquid lysine concentrates are marketed at not less than 50% lysine base, with dry matter contents between 50% and 55%, pH values commonly in the range of 4.0 to 7.0, and density between 1.15 g/cm³ and 1.20 g/cm³ at 20°C. L-lysine monohydrochloride is listed in 21 CFR 573.540 for use in animal feeds, and the chemical entity carries CAS Registry Number 657-27-2.Industrial production of feed-grade lysine uses metabolically engineered strains of Corynebacterium glutamicum or related coryneform bacteria with deregulated aspartate kinase and high flux through the diaminopimelate pathway. The fermentation broth is separated by centrifugation, acidified with hydrochloric acid for the hydrochloride salt, concentrated, crystallized, and dried; the remaining mother liquor and biomass can be further processed into liquid lysine concentrates or granulated L-lysine sulfate. Because the production route is microbial, control of endotoxins, mycotoxins, and viable cells is not the primary quality risk; the main hazards are heavy metals from process water and acid, ammonia carryover, optical isomer purity, and residual sulfate or chloride balance. Feed-grade material is not intended for human use but must comply with animal feed contaminant limits in the destination jurisdiction.In monogastric metabolism, lysine functions as an essential amino acid that cannot be synthesized de novo; in the prepubertal pig and growing broiler, dietary deficiency rapidly reduces voluntary feed intake, nitrogen retention, and lean tissue gain. Lysine accounts for approximately 7% of porcine skeletal muscle protein by amino acid mass, and it serves as the first-limiting amino acid in maize–soybean meal swine diets. Beyond protein synthesis, protein-bound lysine residues are methylated to trimethyllysine in the biosynthesis of carnitine, the carrier molecule required for transport of long-chain fatty acyl groups into the mitochondrial matrix for β-oxidation. Lysyl oxidase catalyses oxidative deamination of lysine side chains in tropocollagen to peptidyl α-aminoadipic-δ-semialdehyde; subsequent aldol condensation and Schiff-base formation create covalent interchain cross-links in collagen, which determine meat texture and bone matrix tensile strength. The metabolic pathways are clinically relevant because a feed ingredient may contain analytically measurable lysine yet fail to support growth if the ε-amino group has been blocked by Maillard adducts during drying or pelleting.Bioavailability of crystalline L-lysine hydrochloride is generally considered to be near 100% relative to lysine in intact feed proteins when measured by slope-ratio growth assay or standardized ileal digestibility coefficients; however, equivalence is conditional on methionine and threonine status, total crude protein floor, and the absence of reducing-sugar-mediated Maillard damage during processing. Commercial L-lysine sulfate also has high bioavailable lysine content but contains fermentation co-products that contribute to crude protein, minerals, and soluble carbohydrate; its lysine bioavailability is not inferior to the hydrochloride when evaluated on an equimolar lysine base basis. Liquid lysine concentrates require metering and mixer validation because the product exhibits a density above water and can stratify in large storage tanks if not recirculated; the viscosity of liquid lysine at 25°C is commonly between 50 mPa·s and 150 mPa·s, which is sufficiently low for diaphragm or peristaltic dosing but high enough to produce pump cavitation if lines are unheated at 10°C. Absorption of lysine from the small intestine is mediated predominantly by the y+ transport system and b0,+ system, with competition from arginine at pharmacological levels of arginine supplementation; in practical diets, this interaction is usually negligible because arginine-to-lysine ratios remain within the ranges required for growth. Published data for the specific transporter competition threshold in commercial feed matrices is limited because most production feeding trials use total amino acid ratios rather than intracellular flux measurements.The specification architecture for feed-grade L-lysine hydrochloride is governed by GB/T 18246-2019 for the commercial product; purchaser specifications typically include assay, optical purity, drying loss, ignition residue, ammonium salt, heavy metals, and arsenic. Analytical confirmation is performed by ion-exchange or high-performance liquid chromatography with post-column ninhydrin derivatization or pre-column derivatization, using ISO 13903:2005 as the reference protocol for amino acid contents in feedingstuffs. The hydrochloride form must exhibit a specific rotation of +18.0° to +21.5° at 589 nm and 20°C, confirming the L-isomer; racemic or partially racemized material is excluded by this polarimetric specification. Loss on drying determined according to ISO 6496:1999 is specified at ≤1.0%; crude ash determined according to ISO 5984:2002 is specified at ≤0.3%. Heavy metals as lead are limited to ≤0.003% and arsenic to ≤0.0002% in most trade specifications, reflecting the fermentation and ion-exchange purification route. The sulfate form is specified by lysine base content, loss on drying, ash, and pH; because it contains fermentation biomass, its crude protein contribution to a formulation is appreciable and should be entered as a matrix value rather than a pure nutrient. The liquid form is specified by lysine base concentration, density, viscosity, pH, and microbial stability; storage at 40°C or above accelerates caramelization and precipitates insolubles. Table 1 provides a comparative matrix.ParameterAnalytical methodL-Lysine HClL-Lysine sulfateLiquid concentrateL-Lysine baseISO 13903:2005≥78.8%≥55%≥50%Equivalent HCl saltCalculated≥98.5%Not applicableNot applicableLoss on dryingISO 6496:1999≤1.0%≤3.0%50–55% dry matterCrude ashISO 5984:2002≤0.3%≤4.0%Not specifiedHeavy metals as PbEN 17053:2018≤0.003%≤0.003%≤0.003%Arsenic as AsEN 17053:2018≤0.0002%≤0.0002%Not specifiedSpecific rotationGB/T 18246-2019+18.0° to +21.5°Not specified+18.0° to +21.5°The tolerance for assay error is narrow because lysine is often the most expensive amino acid additive in least-cost formulation. A 0.1% assay deviation on an ingredient specified at 78.8% lysine base changes the delivered lysine in a 5 kg/t inclusion by 0.039% of complete feed, which is close to the difference between adjacent phase-feeding lysine specifications in some finishing rations. For this reason, incoming raw material lots should be tested against the certificate of analysis by ISO 13903:2005 or near-infrared reflectance calibrated to wet chemistry; a standalone NIR model without a validated bias monitoring programme is not accepted for arbitration. Micro-ingredient dosing systems must be calibrated with the specific bulk density and flow index of each lot because crystalline L-lysine HCl bulk density typically ranges from 0.60 kg/L to 0.75 kg/L and the sulfate granule bulk density from 0.55 kg/L to 0.70 kg/L. Screw feeders on micro-dosing systems require loss-in-weight controllers and periodic gravimetric verification against a platform scale to maintain relative standard deviation below 2% of target inclusion.Free ε-amino groups of lysine participate in Maillard condensation with reducing sugars under heat and moisture; the reaction rate is negligible below 70°C at low water activity but becomes operationally significant in conditioning, pelleting, extrusion, and post-pelleting drying. In pelleted swine feeds formulated with high lactose or sucrose byproduct levels and conditioned at 85°C for 60 s, lysine destruction is generally reported below 3% if the reducing sugar content is below 4% and moisture is below 16%; the same formulation can lose measurable lysine when conditioner retention exceeds 90 s and die temperature exceeds 90°C. Extruded aquafeeds are more vulnerable because barrel temperatures of 120°C to 150°C, high shear, and low moisture plasticization create reactive conditions; free lysine added before extrusion may be partially blocked in the pellet matrix without being destroyed, but apparent ileal digestibility can fall if Maillard adducts form. Feed manufacturers may therefore add crystalline lysine after thermal processing by vacuum coating or liquid spraying when the pellet core temperature has fallen below 60°C. Analytical validation of lysine after thermal processing requires measurement of total lysine by ISO 13903:2005 after acid hydrolysis, and in some cases furosine or carboxymethyllysine by liquid chromatography-mass spectrometry to separate intact lysine from early Maillard adducts.During least-cost formulation for growing swine, standardized ileal digestible lysine is expressed as a percentage of 90% dry matter feed. NRC 2012 tabulates SID lysine requirements of 0.98%, 0.85%, 0.71%, and 0.61% for growing-finishing pigs in the 25–50 kg, 50–75 kg, 75–100 kg, and 100–135 kg body weight classes, respectively. A maize–soybean meal diet for 25–50 kg pigs containing 66% maize and 28% soybean meal supplies approximately 0.82–0.87% SID lysine, so the required crystalline L-lysine hydrochloride addition is usually between 1.4 kg/t and 2.0 kg/t depending on soybean meal lysine digestibility and crude protein. The exact addition is solved by least-cost formulation software using SID amino acid coefficients for each batch of raw material, and the result is not a fixed inclusion rate. When distillers dried grains with solubles are added above 10%, the lysine addition rate increases even though dietary crude protein may rise, because the lysine-to-crude-protein ratio of DDGS is lower than soybean meal. Twin-screw mixers with 4 min dry mix time after lysine addition are used to obtain coefficient of variation values below 5% for lysine in complete feed; micro-ingredient addition requires a separate premix with ground limestone or rice hulls as a carrier to avoid segregation in 25 kg bags or bulk bins.Species / phaseLysine requirementBasisReference standardSwine 25–50 kg0.98%SID, 90% DMNRC 2012Swine 50–75 kg0.85%SID, 90% DMNRC 2012Swine 75–100 kg0.71%SID, 90% DMNRC 2012Swine 100–135 kg0.61%SID, 90% DMNRC 2012Broiler 0–3 weeks1.10%TotalNRC 1994Broiler 3–6 weeks1.00%TotalNRC 1994Broiler 6–8 weeks0.85%TotalNRC 1994Rainbow trout2.4%Dry matterNRC 2011Nile tilapia1.5%Dry matterNRC 2011In broiler feeds, lysine is second-limiting after methionine; total lysine requirements published by NRC 1994 are 1.10% for 0–3 weeks, 1.00% for 3–6 weeks, and 0.85% for 6–8 weeks. Modern commercial hybrids are typically fed digestible lysine values above these minima when dietary AME is increased. Layer diets require approximately 0.69% total lysine at 100 g/day feed intake according to NRC 1994; deficiency in early lay reduces egg mass, albumen weight, and feed efficiency rather than egg number alone. Crystalline L-lysine hydrochloride is freely soluble and rapidly absorbed in the upper small intestine of poultry, with apparent ileal digestibility coefficients generally exceeding 95% when measured by slaughter technique or marker-based ileal digesta collection. The product is used in premixes at 0.10–0.30% of final feed to close lysine deficits left by maize, wheat, barley, and soybean meal combinations.At the point where fish meal replacement by soybean meal, rapeseed meal, pea protein concentrate, or maize gluten exceeds the lysine supply threshold, crystalline lysine supplementation becomes necessary in aquafeeds. NRC 2011 lists lysine requirements of 2.4% dry matter for rainbow trout and 1.5% dry matter for Nile tilapia; these values are higher than swine and broiler recommendations because aquatic species oxidize amino acids more extensively and often consume diets with higher protein densities. Extrusion processing of aquafeed at barrel temperatures of 120–150°C creates a risk of lysine loss or reduced ileal digestibility when reducing sugars from wheat flour, wheat gluten, or hydrolysed marine byproducts are present; free lysine inclusion before extrusion is therefore limited to 0.5–1.0% of the dry mix in many production lines when the recipe contains high reducing sugar inputs, with the remainder applied by post-extrusion vacuum coating. Vacuum coaters operating at residual pressures of −0.6 bar to −0.8 bar and product temperatures below 60°C are used to apply liquid lysine concentrates and oil after drying; this sequence protects the ε-amino group from thermal damage and ensures the L-lysine remains on the pellet surface. Floating and sinking extruded feeds can be supplemented with lysine HCl powder if particle size is below 150 µm to allow adequate dispersion in the mash, but fines adhesion to the pellet die face may require binder addition.Feed-grade L-lysine hydrochloride is hygroscopic; sustained exposure to relative humidity above 60% results in moisture uptake, granule bridging in steel silos, and eventually assay loss due to microbial and chemical degradation. The product should not be combined in concentrated premixes with choline chloride in its unprotected form because the two hygroscopic ingredients accelerate water absorption and can form a wet acidic mass; if choline chloride must be included in the same premix, the mixture requires a desiccant and storage time of less than 72 h. The sulfate product is less hygroscopic but has a higher ash and crude protein contribution, so it may alter dietary electrolyte balance and pellet durability when included at high levels. Liquid lysine concentrates require agitation and temperature control; viscosity increases at temperatures below 10°C and can cause metering pump cavitation in unheated lines. Storage of liquid lysine in stainless steel tanks with recirculation at 20–30°C is typical to maintain homogeneity; bulk tanks should be inspected for crystalline deposition at liquid-vapour interfaces.

Pharmaceutical-grade lactic acid as described in the current USP-NF, Ph Eur, and BP monographs is a concentrated aqueous equilibrium mixture of free lactic acid, lactoyllactic acid, water, and minor oligomeric esters; it is not an anhydrous single entity with a fixed water-free purity. The pharmacopoeial assay expresses total acid equivalents as C3H6O3 after alkaline hydrolysis, using an equivalence factor of 90.08 mg of C3H6O3 per millilitre of 1 N sodium hydroxide in the USP procedure and 90.1 mg per millilitre of 1 M sodium hydroxide in the Ph Eur procedure. USP-NF allows not less than 85.0% w/w and not more than 92.0% w/w of C3H6O3, while Ph Eur and BP specify 88.0% w/w to 92.0% w/w. The difference between the two assay ranges has direct consequences for global formulation development because a 100.0 g quantity of USP-grade material at the lower limit contains 85.0 g of titratable acid equivalents, whereas a Ph Eur-grade batch at the lower limit contains 88.0 g; if the same nominal percentage is used in a master formula without lot-specific assay correction, the resulting pH and buffer capacity can differ by approximately 3% relative. The free acid in concentrated solution is partially esterified to lactoyllactic acid, and the ester fraction increases with decreasing water activity and rising storage temperature, so the titrimetric assay is intentionally preceded by saponification or is designed to hydrolyse the ester before the final titration. This equilibrium behaviour also means that density, refractive index, or conductivity alone cannot substitute for the compendial assay in release testing; a density meter may provide a rapid in-process concentration estimate, but the release specification remains the titrated acid equivalent value. The Ph Eur monograph describes the article as clear, colourless or slightly yellow, syrupy, and miscible with water and ethanol; the USP monograph similarly includes limits for reducing sugars and for citric, oxalic, tartaric, and phosphoric acids to exclude poorly purified fermentation or synthetic material.Across the current USP-NF, Ph Eur, and BP monographs, inorganic and organic impurities are controlled through a combination of specific ion tests, colourimetric or titrimetric limit tests, and liquid chromatography in the Ph Eur/BP text. Chloride in the Ph Eur/BP monograph is controlled at not more than 100 ppm, sulfate at not more than 200 ppm, and calcium at not more than 200 ppm; the USP monograph does not set the same individual ion limits but applies heavy metals at not more than 0.001%, equivalent to 10 ppm, and a residue on ignition limit of not more than 0.1%. The Ph Eur/BP monograph also includes a lead limit at not more than 5 ppm in editions where lead is separately controlled, and a liquid chromatographic related substances test to limit acetic acid, formic acid, and unspecified impurities; the assay by titration cannot distinguish these organic acids, so the chromatographic method is required when monograph compliance is claimed. For residual solvents, synthetic material produced through the lactonitrile route may contain methanol and acetaldehyde-derived impurities; the finished pharmaceutical dosage form must comply with ICH Q3C residual solvent limits, with methanol assigned as a Class 2 solvent with a 30 mg/day permitted daily exposure and a 3000 ppm Option 1 concentration limit. Suppliers of pharmaceutical-grade lactic acid typically set internal methanol limits below 50 ppm because the excipient may be used at several percent in a formulation, and the residual solvent contribution must remain below the finished-product limit. The difference between USP-NF and Ph Eur/BP assay ranges should not be interpreted as a difference in purity strategy but as different monograph histories; a supplier can provide a single bulk material that meets both sets of tests only when the assay result is constrained to the overlapping 88.0% w/w to 92.0% w/w window.ParameterUSP-NF Lactic AcidPh Eur/BP Lactic AcidMethod anchorAssay as C3H6O385.0–92.0% w/w88.0–92.0% w/wUSP <541>; Ph Eur 2.2.20Chloridenot individually specified in the general monograph≤100 ppmPh Eur 2.4.4Sulfatenot individually specified≤200 ppmPh Eur 2.4.13Calciumnot individually specified≤200 ppmPh Eur 2.4.3Heavy metals≤10 ppm≤10 ppmUSP <231> historical; Ph Eur 2.4.8Reducing sugarspasses compendial limit testpasses compendial limit testmonograph-specificIn bulk pharmaceutical manufacture, lactic acid can be produced by fermentative homolactic fermentation of carbohydrate substrates or by synthetic hydrolysis of lactonitrile; the two routes generate different enantiomeric profiles. Fermentation with Lactobacillus or Bacillus coagulans yields predominantly L-(+)-lactic acid, whereas the synthetic lactonitrile route produces a racemic mixture unless an asymmetric step or enzymatic resolution is introduced. USP and Ph Eur general monographs for Lactic Acid do not consistently require a specific optical rotation when the label does not claim a single enantiomer; when the material is labelled as L-(+)-lactic acid, the formulator should apply additional identification and chiral purity methods, because the ordinary acid-base titration cannot distinguish D- and L-isomers. Specific optical rotation at 589 nm is used as a screening test, and chiral liquid chromatography or enzymatic assay is used to quantify D-isomer content when the final dosage form has a stereochemical specification. The presence of D-lactic acid is relevant in parenteral nutrition and in infant formulations because D-lactate clearance in humans is slower than L-lactate clearance; published clinical data for paediatric D-lactate acidosis have made enantiomeric purity a significant quality attribute in enteral and parenteral products. For general topical and oral solid dose applications, the racemic mixture is often acceptable, but formulators should not assume that a USP or Ph Eur Lactic Acid certificate provides enantiomeric purity unless the certificate includes a specific optical rotation value and a chiral purity result.Because the acid at pH below 2.0 promotes corrosion in carbon steel, pharmaceutical lactic acid bulk storage and transfer require compatibility with stainless steel 316L or glass-lined equipment; carbon steel is not suitable, and chloride present from fermentation can initiate pitting even in stainless grades at elevated temperature. In bulk receiving, a 1000-L stainless steel 316L receiving tank with a bottom recirculation loop and an in-line pH probe is typically used; sampling after recirculation for at least 30 min reduces top-to-bottom assay variation caused by water vapour exchange at the tank headspace. The standard 88–92% w/w material has a density of approximately 1.20–1.22 g/cm³ at 20 °C and a dynamic viscosity in the range of 40–70 mPa·s at 25 °C; viscosity rises rapidly below 15 °C, and transfer lines should be heat-traced if the material is stored in cold warehouses. Fermentation-derived material is typically purified by acidulation of calcium lactate with sulfuric acid followed by filtration to remove gypsum, then esterification to methyl lactate, distillation, and hydrolysis; this sequence reduces calcium, sulfate, and reducing sugar impurities to compendial levels. Synthetic material from lactonitrile requires rigorous removal of methanol, acetaldehyde, and cyanide-related intermediates; residual solvent certificates should include methanol and acetaldehyde data in addition to the ICH Q3C declarations. Ph Eur/BP and USP monographs impose heavy metal limits, but a modern excipient dossier should also provide elemental impurity data under ICH Q3D using USP <232>/<233> or Ph Eur 5.20, because the traditional heavy metals test does not quantify individual elements with sufficient sensitivity for parenteral applications. The formulator should verify that the supplier has evaluated chromium, nickel, molybdenum, and iron if the material has been held in stainless steel equipment; published data for specific batches may be limited, and a risk assessment should be performed rather than relying solely on the monograph test.In pharmaceutical formulation practice, lactic acid functions primarily as an acidulant, pH adjuster, and component of lactate buffer systems. The pKa of lactic acid at 25 °C is 3.86; the useful buffer range is therefore approximately 2.8–4.8. A 10% w/w aqueous solution has a pH of approximately 1.8–2.2 at 25 °C when measured per USP <791> or Ph Eur 2.2.3. For pH adjustment from neutral to acidic pH in topical gels, a diluted 10% w/w lactic acid solution is often used to avoid local pH overshoot and precipitation of polymers such as carbomer or xanthan gum; direct addition of concentrated 88–92% w/w acid to polymer dispersions can create low-pH microenvironments that reduce viscosity or cause coagulation before mixing is complete. In oral liquids, lactic acid may be used at low percentages to acidulate a buffered sorbitol or sucrose vehicle; the amount required is calculated from the buffer capacity of the vehicle and the target pH, but the titration curve must be generated experimentally because the presence of weak acid preservatives such as sorbic or benzoic acid shifts the pH response. Sodium lactate 60% w/w solution is used in lactated Ringer's injection and in some electrolyte concentrates; the ratio of lactic acid to sodium lactate is adjusted to provide the desired pH and sodium load. The formulator should not use lactic acid as a sole preservative; its antimicrobial action is pH-dependent and unreliable above pH 4.5, and preservation must be confirmed by compendial antimicrobial effectiveness testing USP <51> or Ph Eur 5.1.3.Although pharmaceutical-grade lactic acid is suitable for topical, oral, and some parenteral pH adjustment, it is not automatically equivalent to polymer-grade lactic acid used in poly(lactic acid) or poly(lactic-co-glycolic acid) synthesis because the polymer route requires conversion to lactide and control of water, free acid, and metal catalyst residues at much tighter levels. The polymerization process usually begins with oligomerization of lactic acid under reduced pressure at 130–180 °C, followed by depolymerization in the presence of tin(II) 2-ethylhexanoate at 0.02–0.05 wt% to produce lactide; the catalyst level and the free acid content of the feedstock influence molecular weight and degradation kinetics. Water above 0.05% w/w in the lactide feedstock hydrolyses lactide to lactic acid and reduces ring-opening polymerization efficiency; therefore, polymer producers specify a water limit that is far below the water content of 8–15% w/w present in pharmaceutical-grade lactic acid solution. The compendial assay and impurity tests do not provide tin content, monomeric hydroxy acid ratio, or acid value at the levels needed for sustained-release polymer manufacture; a separate specification aligned with the supplier's technical data package is required. Formulators developing drug-eluting implants should therefore treat the excipient grade as a starting material rather than a direct monomer source; published data for the conversion of compendial lactic acid to polymer-grade lactide in specific reactor trains is limited, and each campaign should include stress testing for residual lactide, tin, and free acid in the final polymer.Thermal stability of pharmaceutical lactic acid solutions is governed by esterification of free acid to lactoyllactic acid, oligomer formation, and dehydration reactions that become significant above 100 °C and are accelerated by acid catalysis; the reaction mixture at high temperature can generate lactide, acetaldehyde, carbon monoxide, and water as volatile degradation products. In aqueous formulation matrices at ambient temperature, lactic acid is chemically stable over the pH range 2.0–6.0 for at least 24 months when stored in tight containers, but the exact shelf life must be established under ICH Q1A conditions for the specific formulation. Exposure to strong oxidising agents such as hypochlorite or concentrated nitric acid can generate carbon dioxide and acetic acid; contact with amines can form lactate salts or amides if water is removed. Lactic acid chelates divalent metals, and this property can be beneficial in preventing trace metal oxidation in topical formulations, but it also causes incompatibility with calcium-containing emulsifiers and hard water; a 10% w/w dilution in hard water can precipitate calcium lactate at low temperature. Packaging for bulk pharmaceutical lactic acid is typically high-density polyethylene or stainless steel 316L; glass is acceptable if the closure prevents moisture ingress, because water uptake from humid air will reduce the assay and water loss will increase viscosity and ester content. Stability-indicating methods should include titrimetric assay, pH, density, and liquid chromatography for related substances; the titration alone will not detect a shift in oligomer distribution if acid equivalents are preserved, so a viscosity or density check is often added for routine release of bulk stored material.For in-house qualification of a lactic acid excipient lot, the release testing sequence should be designed around the compendial monographs plus the application-specific attributes for the dosage form. The testing sequence usually includes appearance, infrared identification against a reference standard, titrimetric assay after alkaline hydrolysis, limit tests for chloride, sulfate, calcium, heavy metals, reducing substances, and residual solvents when the supply chain uses a synthetic route. For parenteral development, the lot should also be tested for bacterial endotoxins per USP <85> or Ph Eur 2.6.14, and for particulate matter in the diluted solution if the manufacturing process does not include a validated filtration step. The compendial methods for these tests are summarised below; the table is a compliance checklist for method transfer rather than a replacement for the mandatory current USP-NF, Ph Eur, and BP texts. Method verification should be performed under the site's quality system, and compendial method equivalency should be demonstrated for each new supplier because trace impurities from different fermentation substrates or synthetic routes can affect retention times and detector response.Test areaUSP referencePh Eur/BP referenceTypical applicationTitrimety after alkaline hydrolysisUSP <541>Ph Eur 2.2.20Assay of total acid equivalentspHUSP <791>Ph Eur 2.2.310% solution pH and formulation pHInfrared identificationUSP <197>Ph Eur 2.2.24Identity confirmationLiquid chromatographyUSP <621>Ph Eur 2.2.29Related substances and chiral purityOptical rotationUSP <781>Ph Eur 2.2.7Enantiomer screeningElemental impuritiesUSP <232>/<233>Ph Eur 5.20ICH Q3D risk assessmentWater determinationUSP <921>Ph Eur 2.5.12Water content and dilution correctionBacterial endotoxinsUSP <85>Ph Eur 2.6.14Parenteral formulation releaseResidual solventsUSP <467>Ph Eur 5.4Methanol, acetaldehyde controlThe monograph texts for lactic acid are revised as part of the pharmacopoeial revision cycle; formulators should verify the current edition and the specific supplier certificate against the intended dosage form. A single certificate of analysis stating “USP/EP/BP grade” is not sufficient for a parenteral dossier unless the certificate includes the additional endotoxin, elemental impurity, and residual solvent data required by ICH Q3C and ICH Q3D. Batch-to-batch variability in the ratio of free acid to lactoyllactic acid can influence pH adjustment calculations in weakly buffered systems, so the formulation development report should record the lot assay, water content, density, and titration curve rather than assuming a fixed concentration from the label alone. This approach permits lot substitution across USP and Ph Eur/BP grades without altering the final product pH, buffer capacity, or electrolyte balance.